In conclusion, our study identifies the genetic basis of NYS4, expands the spectrum of FGF14 variants, refines the phenotypes of the associated oculomotor anomalies, and demonstrates the value of screening FGF14 in children with apparently isolated early onset nystagmus. The gene discussed is FGF14; the disease is pathologic nystagmus.